Urine-Based Molecular Test for Prostate Cancer Available
miR Sentinel is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm.
Read MorePosted by Chris Wolski | Jul 13, 2022 | Prostate |
miR Sentinel is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm.
Read MorePosted by Chris Wolski | Apr 29, 2022 | Prostate |
The incidence of more aggressive prostate cancer cases that are higher-grade disease and metastasis at diagnosis have risen.
Read MorePosted by Andy Lundin | Apr 12, 2022 | Prostate |
PSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.
Read MorePosted by Andy Lundin | Mar 17, 2022 | Digital Pathology, Prostate |
Digital pathology solutions provider Lumea and Verily, an Alphabet a precision health company,...
Read MorePosted by Andy Lundin | Mar 14, 2022 | Prostate |
The incidence rate of metastatic prostate cancer increased for men 45 and older and coincides with recommendations against screenings.
Read More